US OptionsDetailed Quotes

INCR241220P2500

Watchlist

1.20
0.000.00%

15min DelayTrading Nov 29 10:01 ET

0.00High0.00Low

InterCure Stock Discussion

Jaguar8

May 1 11:51

$InterCure (INCR.US)$
NEWS
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
InterCure achieved annual revenue of NIS 356 million and adjusted EBITDA of NIS 61 million, representing 17% of revenues.
The company maintained profitability for the fourteenth and fifteenth consecutive quarters despite challenges.
InterCure continues to expand its product portfolio and dedicated medical cannabis pharmacy chain.
The company is entitled to full compensat...

Moomoo AI

Jan 31 08:37

InterCure's CEO sees the acquisition of Leon Pharm as a move towards implementing new medical cannabis reform and catering to unique patient needs in Israel. This is expected to bolster InterCure's market dominance.

Press Release: InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

BEAN8444

Jul 26, 2023 18:31

$InterCure (INCR.US)$Intercure Announces Proposed Voluntary Delisting From The Toronto Stock Exchange And Shall Continue To Be Listed On The Nasdaq And TASE